Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Eli Lilly Wins Longer Halt|on Generic Strattera Drug

(CN) - The Federal Circuit extended an order temporarily blocking generic versions of Eli Lilly & Co.'s Strattera while the pharmaceutical giant appeals a ruling invalidating its U.S. patent for the drug used to treat attention-deficit hyperactivity disorder.

The federal appeals court in Washington, D.C., extended the temporary stay granted by a federal judge in New Jersey, who found Strattera's U.S. patent invalid earlier this month, thus removing its patent protection against generic versions.

The court allowed the patent protection to stay in place until the court hears Eli Lilly's appeal, which could take more than a month.

The original stay order was set to expire after two weeks, but will now remain in place pending appeal.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...